AnaptysBio Inc (ANAB)
25.06
-0.40
(-1.59%)
USD |
NASDAQ |
May 17, 16:00
25.06
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 1.375M |
| September 30, 2019 | 3.077M |
| June 30, 2019 | 4.781M |
| Date | Value |
|---|---|
| March 31, 2019 | 6.488M |
| December 31, 2018 | 7.574M |
| September 30, 2018 | 9.909M |
| June 30, 2018 | 11.62M |
| March 31, 2018 | 13.33M |
| December 31, 2017 | 14.43M |
| September 30, 2017 | 14.27M |
| June 30, 2017 | 14.11M |
| March 31, 2017 | 13.96M |
| December 31, 2016 | 13.81M |
| September 30, 2016 | 4.983M |
| June 30, 2016 | 4.953M |
| March 31, 2016 | 4.925M |
| December 31, 2015 | 4.903M |
| September 30, 2015 | 4.876M |
| June 30, 2015 | 4.848M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 4.793M |
| September 30, 2014 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
4.781M
Maximum
Jun 2019
0.4617M
Average
--
Median
Mar 2020
Total Long Term Debt (Quarterly) Benchmarks
| XOMA Corp | 120.67M |
| Fate Therapeutics Inc | 0.00 |
| Ocular Therapeutix Inc | 66.46M |
| Apellis Pharmaceuticals Inc | 93.11M |
| Sutro Biopharma Inc | 0.00 |